http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1429573-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-4006
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-16
filingDate 1973-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1976-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1429573-A
titleOfInvention Cephalosporines
abstract 1429573 Epimerization of 7α-amino-cephalosporins; preparing phosphonate ester and other intermediates; organolithium compound MERCK & CO Inc 10 Dec 1973 [12 Dec 1972] 57162/73 Headings C2C C2P and C2J [Also in Division A5] 7α-Amino-cephalosporins of the general formula wherein R 1 is a blocking group, R<SP>1</SP> is a C 2-6 alkanoyl group and R 5 is a C 1-3 alkyl group, are epimerized by reacting them with an aromatic aldehyde, treating the resulting novel 7α-iminocephalosporin of the general formula wherein R 2 is an arylmethylene radical, with a strong base, e.g. phenyllithium, which forms the corresponding 7-Li derivative, in the presence of an aprotic solvent and a dipolar aprotic cosolvent, followed by acidification and reacting the resulting novel 7#-imino-cephalosporin of the general formula with an acid in the presence of an amine or with p-toluenesulphonic acid in ethereal solution to give the desired 7#-amino-cephalosporin, which may subsequently be N-acylated, hydrolysed and salified to give an antibacterial 7#-acylamino-3-cephem-4-carboxylic acid salt. 7α-Amino-cephalosporins of the first general formula above are prepared by reacting compounds of the general formulµ and wherein R is an aryl or C 1-6 alkyl group and X is a halogen atom or leaving group, treating the resulting phosphonoacetate of the general formula with a base, reacting the resulting thiazine of the general formula with azidoacetyl chloride in the presence of an acid scavenger and reducing the resulting 7α- azido-cephalosporin of the general formula 1 - Chloro - 3 - acetoxy - butan - 2 - one is prepared by treating 2-acetoxypropionyl chloride with diazomethane, followed by hydrochloric acid. p - Methoxybenzyl α - thioformamido - diethyl phosphonoacetate is prepared by reacting benzylamine with formaldehyde and diethyl phosphite, hydrogenating the resulting diethyl N-benzylaminomethylphosphonate (optionally isolated as the hydrochloride), treating the resulting diethyl aminomethylphosphonate hydrochloride with benzaldehyde, reacting the resulting diethyl N- benzylidene - aminomethyl - phosphonate with phenyllithium and p-methoxybenzyl chloroformate, treating the resulting p-methoxybenzyl N - benzylidene - α - amino - diethylphosphonoacetate with p-toluenesulphonic acid in ether and reacting the resulting p-methoxybenzyl α-aminodiethylphosphonoacetate with ethyl thioformate in the presence of liquid hydrogen sulphide.
priorityDate 1972-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426203400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531457
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426037970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421018552
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9550
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425901710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3780918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414026254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411276796
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416183702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7504
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID140799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2773681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10923173
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53833759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423416272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12866379
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421348909
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12866380
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457778337
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53831774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12753802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421208046
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452118476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15789245
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13305526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420174747
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410471442
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414026222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426002357
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4547492
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10909558

Total number of triples: 61.